Personalis, Inc. (PSNL)
16.21
-0.12
(-0.73%)
USD |
NASDAQ |
Sep 11, 16:00
16.22
+0.01
(+0.06%)
After-Hours: 20:00
Personalis Enterprise Value : 1.550B for Sept. 11, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 11, 2026 | 1.550B |
| September 10, 2026 | 1.562B |
| September 09, 2026 | 1.570B |
| September 08, 2026 | 1.591B |
| September 04, 2026 | 1.655B |
| September 03, 2026 | 1.616B |
| September 02, 2026 | 1.605B |
| September 01, 2026 | 1.640B |
| August 31, 2026 | 1.610B |
| August 28, 2026 | 1.641B |
| August 27, 2026 | 1.612B |
| August 26, 2026 | 1.642B |
| August 25, 2026 | 1.660B |
| August 24, 2026 | 1.640B |
| August 21, 2026 | 1.780B |
| August 20, 2026 | 1.621B |
| August 19, 2026 | 1.507B |
| August 18, 2026 | 1.305B |
| August 17, 2026 | 1.303B |
| August 14, 2026 | 1.319B |
| August 13, 2026 | 1.359B |
| August 12, 2026 | 1.337B |
| August 11, 2026 | 1.317B |
| August 10, 2026 | 1.368B |
| August 07, 2026 | 1.332B |
| Date | Value |
|---|---|
| August 06, 2026 | 1.211B |
| August 05, 2026 | 1.263B |
| August 04, 2026 | 1.263B |
| August 03, 2026 | 1.229B |
| July 31, 2026 | 1.172B |
| July 30, 2026 | 1.132B |
| July 29, 2026 | 1.073B |
| July 28, 2026 | 1.089B |
| July 27, 2026 | 1.100B |
| July 24, 2026 | 1.078B |
| July 23, 2026 | 1.125B |
| July 22, 2026 | 1.152B |
| July 21, 2026 | 1.255B |
| July 20, 2026 | 1.244B |
| July 17, 2026 | 1.462B |
| July 16, 2026 | 1.483B |
| July 15, 2026 | 1.505B |
| July 14, 2026 | 1.424B |
| July 13, 2026 | 1.425B |
| July 10, 2026 | 1.322B |
| July 09, 2026 | 1.384B |
| July 08, 2026 | 1.326B |
| July 07, 2026 | 1.312B |
| July 06, 2026 | 1.351B |
| July 02, 2026 | 1.274B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| 10X Genomics, Inc. | 8.463B |
| Tempus AI, Inc. | 11.25B |
| Alamar Biosciences, Inc. (California) | 1.737B |
| Adaptive Biotechnologies Corp. | 3.923B |
| Champions Oncology, Inc. | 78.16M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -31.68M |
| Revenue (Quarterly) | 22.36M |
| Total Expenses (Quarterly) | 54.04M |
| EPS Diluted (Quarterly) | -0.3005 |
| Gross Profit Margin (Quarterly) | 21.21% |
| Profit Margin (Quarterly) | -141.7% |
| Earnings Yield | -6.73% |
| Normalized Earnings Yield | -6.730 |